Original ResearchHealth-related quality of life results from the phase III CheckMate 067 study
Under a Creative Commons license
open access
Keywords
Health-related quality of life
Checkpoint inhibitors
Advanced melanoma
Nivolumab
Ipilimumab
Cited by (0)
© 2017 The Authors. Published by Elsevier Ltd.